Also trades as: NBRV (NASDAQ) · $vol 0M
NBRVF OTC
Nabriva Therapeutics plc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -0.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$37M
+38.4% ▲
Capital Expenditures
$211K
-744.0% ▼
5Y CAGR: -29.0%
Free Cash Flow
-$37M
+38.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$35M
-665.3% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$115M | -$83M | -$69M | -$49M | -$57M |
| Depreciation & Amort. | $510K | $770K | $820K | $637K | $217K |
| Stock-Based Comp. | $0 | $10M | $5M | $3M | $2M |
| Change in Working Capital | $4M | -$195K | -$11M | -$15M | $14M |
| Other Non-Cash Items | $32M | $549K | $748K | $822K | $5M |
| Operating Cash Flow | -$73M | -$72M | -$71M | -$60M | -$37M |
| — Investing Activities — | |||||
| Capital Expenditures | -$229K | -$61K | -$113K | -$25K | -$211K |
| Acquisitions (Net) | -$4M | $0 | $0 | $0 | $0 |
| Investment Purchases | -$115K | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $392K | -$161K | -$56K | -$52K |
| Investing Cash Flow | -$5M | $331K | -$274K | -$81K | -$263K |
| — Financing Activities — | |||||
| Net Debt Issuance | $24M | $10M | -$30M | $0 | -$3M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $19M | $26M | $3M | $38M | $3M |
| Financing Cash Flow | $93M | $56M | $27M | $66M | $2M |
| Net Change in Cash | $15M | -$16M | -$45M | $6M | -$35M |
| Cash End of Period | $102M | $86M | $42M | $48M | $13M |
| Free Cash Flow | -$73M | -$72M | -$71M | -$60M | -$37M |